Christianne Groeneveldt

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Nature communications

Cancer immunology research

Cancer research communications

Journal for immunotherapy of cancer

Leids Universitair Medisch Centrum

Leiden University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leids Universitair Medisch Centrum Oct 16 2018

Netherlands

PhD student :: Medical Oncology

Education History

Leiden University Sep 01 2016 - Jul 11 2018

Netherlands

MSC :: BioTherapeutics

Publications

Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing antibodies impair the oncolytic efficacy of reovirus but permit effective combination with T cell-based immunotherapies. Cancer immunology research (2024)
Jim Middelburg, Marjolein Sluijter, Gaby Schaap, Büşra Göynük, Katy Lloyd, Vitalijs Ovcinnikovs, Gijs G Zom, Renoud J Marijnissen, Christianne Groeneveldt, Lisa Griffioen, Gerwin G W Sandker, Sandra Heskamp, Sjoerd H van der Burg, Tsolere Arakelian, Ferry Ossendorp, Ramon Arens, Janine Schuurman, Kristel Kemper, Thorbald van Hall
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors. Nature communications 15 (1) (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies. Cancer immunology research 12 (3) (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies. Cancer immunology research 12 (3) (2024)
Jim Middelburg, Marjolein Sluijter, Gaby Schaap, Büşra Göynük, Katy Lloyd, Vitalijs Ovcinnikovs, Gijs G Zom, Renoud J Marijnissen, Christianne Groeneveldt, Lisa Griffioen, Gerwin G W Sandker, Sandra Heskamp, Sjoerd H van der Burg, Tsolere Arakelian, Ferry Ossendorp, Ramon Arens, Janine Schuurman, Kristel Kemper, Thorbald van Hall
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors. Nature communications 15 (1) (2024)
Jim Middelburg, Marjolein Sluijter, Gaby Schaap, Büşra Göynük, Katy Lloyd, Vitalijs Ovcinnikovs, Gijs G Zom, Renoud J Marijnissen, Christianne Groeneveldt, Lisa Griffioen, Gerwin G W Sandker, Sandra Heskamp, Sjoerd H van der Burg, Tsolere Arakelian, Ferry Ossendorp, Ramon Arens, Janine Schuurman, Kristel Kemper, Thorbald van Hall
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors. Nature communications 15 (1) (2024)
Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman, Marjolein Sluijter, Lisa Griffioen, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Sjoerd H Van der Burg, Peter Ten Dijke, Lukas J A C Hawinkels, Thorbald van Hall, Nadine van Montfoort
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy. Cancer research communications 3 (2) (2023)
Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman, Marjolein Sluijter, Lisa Griffioen, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Sjoerd H Van der Burg, Peter Ten Dijke, Lukas J A C Hawinkels, Thorbald van Hall, Nadine van Montfoort
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy. Cancer research communications 3 (2) (2023)
Selas T F Bots, Tom J Harryvan, Christianne Groeneveldt, Priscilla Kinderman, Vera Kemp, Nadine van Montfoort, Wytske M van Weerden
Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma. Molecular oncology (2023)
Christianne Groeneveldt, Priscilla Kinderman, Diana J M van den Wollenberg, Ruben L van den Oever, Jim Middelburg, Dana A M Mustafa, Wytske M van Weerden, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy. Journal for immunotherapy of cancer 8 (2) (2021)
Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman, Melanie Lukkes, Larissa Klaase, Menno van Nimwegen, Mandy van Gulijk, Jasper Dumas, Dana A M Mustafa, Sanne L A Lievense, Christianne Groeneveldt, Ralph Stadhouders, Yunlei Li, Andrew Peter Stubbs, Koen A Marijt, Heleen Vroman, Sjoerd H van der Burg, Joachim Aerts, Thorbald van Hall, Floris Dammeijer, Casper H J van Eijck
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model. Journal for immunotherapy of cancer 8 (2) (2021)
Siri Tähtinen, Sara Feola, Cristian Capasso, Netta Laustio, Christianne Groeneveldt, Erkko O Ylösmäki, Beatriz Martins, Manlio Fusciello, Marta Medeot, Maria Tagliamonte, Jacopo Chiaro, Firas Hamdan, Karita Peltonen, Tuuli Ranki, Luigi Buonaguro, Vincenzo Cerullo
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy. Cancer research 80 (12) (2020)

Christianne Groeneveldt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christianne Groeneveldt